This article was first published in the Bio-science Law Review (Volume 19, Issue 6) by Lawtext Publishing. Cell and Gene Therapies...

In 2024 biotech venture funding in Europe and the US saw a promising increase, reaching a total of $28.1 billion up from $21.2 billion...

The Commission is taking its regular look at the competition rules and guidance applicable to technology licensing agreements, in advance...

The recent social media discussions around the well-known dessert company, Doughnut Time, are a reminder to franchise owners and...

In late 2024, Mr. Justice Adam Johnson delivered his judgment in Zaha Hadid Ltd v Zaha Hadid Foundation [2024] EWHC 3325 (Ch), offering...

As with most industries, sustainability has become a key focus for the fashion and luxury goods industry. In recent years, this has led...

In London last week, over 400 attendees and speakers gathered together for the fifth annual SynbiTECH conference in London. The event...

As briefly mentioned in our article last week on Priority Review Vouchers, the financial terms of a biopharma patent licence agreement...

The licensing of content for AI model training is on the rise. Amid reports that developers are facing a scarcity of content to train AI...

On 5 November 2024, Acadia Pharmaceuticals Inc. ("Acadia") announced that it sold its rare paediatric disease priority review voucher...

In this episode, Camille Beckmann speaks to Anneke Pol and Vik Khurana (along with a special guest AI chatbot!) on how to structure...

On 24 October 2024, Cancer Research UK ("CRUK") and KisoJi Biotechnology Inc. ("KBI") announced that they have entered into an agreement...